Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Maria Lopes-Virella
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Disorders
Anatomy
Phenomena
Sign-in to see full Profile
Network (preview)
58
Virella, Gabriel
25
Colwell, John
22
Huang, Yan
20
Klein, Richard
11
Nareika, Alena
9
Mironova, Marina
9
Game, Bryan
8
Sanders, John
6
Thorpe, Suzanne
6
Koskinen, Sinikka
6
Jenkins, Alicia
6
Sagel, Julius
6
Slate, Elizabeth
5
Mayfield, Ronald
5
Chassereau, Charlyne
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Maria Lopes-Virella (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Paterson Andrew D; Lopes-Virella Maria F; Waggott Daryl; Boright Andrew P; Hosseini S Mohsen; Carter Rickey E; Shen Enqing; Mirea Lucia; Bharaj Bhupinder; Sun Lei; Bull Shelley B;
Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(11):1958-67.
-
2009: Fernandes Jyotika K; Wiegand Ryan E; Salinas Carlos F; Grossi Sara G; Sanders John J; Lopes-Virella Maria F; Slate Elizabeth H
Periodontal disease status in gullah african americans with type 2 diabetes living in South Carolina.
Journal of periodontology 2009;80(7):1062-8.
-
2009: Sundararaj Kamala P; Samuvel Devadoss J; Li Yanchun; Sanders John J; Lopes-Virella Maria F; Huang Yan
Interleukin-6 released from fibroblasts is essential for up-regulation of matrix metalloproteinase-1 expression by U937 macrophages in coculture: cross-talking between fibroblasts and U937 macrophages exposed to high glucose.
The Journal of biological chemistry 2009;284(20):13714-24.
-
2009: Samuvel Devadoss J; Sundararaj Kamala P; Nareika Alena; Lopes-Virella Maria F; Huang Yan
Lactate boosts TLR4 signaling and NF-kappaB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(4):2476-84.
-
2009: Hammad Samar M; Twal Waleed O; Barth Jeremy L; Smith Kent J; Saad Antonio F; Virella Gabriel; Argraves W Scott; Lopes-Virella Maria F
Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells.
Atherosclerosis 2009;202(2):394-404.
-
2009: Nareika Alena; Sundararaj Kamala P; Im Yeong-Bin; Game Bryan A; Lopes-Virella Maria F; Huang Yan
High glucose and interferon gamma synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor STAT1 activity.
Atherosclerosis 2009;202(2):363-71.
-
2008: Cole C M; Sundararaj K P; Leite R S; Nareika A; Slate E H; Sanders J J; Lopes-Virella M F; Huang Y
A trend of increase in periodontal interleukin-6 expression across patients with neither diabetes nor periodontal disease, patients with periodontal disease alone, and patients with both diseases.
Journal of periodontal research 2008;43(6):717-22.
-
2008: Lopes-Virella Maria F; Carter Rickey E; Gilbert Gregory E; Klein Richard L; Jaffa Miran; Jenkins Alicia J; Lyons Timothy J; Garvey W Timothy; Virella Gabriel;
Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications.
Diabetes care 2008;31(10):2006-12.
-
2008: Sundararaj Kamala P; Samuvel Devadoss J; Li Yanchun; Nareika Alena; Slate Elizabeth H; Sanders John J; Lopes-Virella Maria F; Huang Yan
Simvastatin suppresses LPS-induced MMP-1 expression in U937 mononuclear cells by inhibiting protein isoprenylation-mediated ERK activation.
Journal of leukocyte biology 2008;84(4):1120-9.
-
2008: Virella Gabriel; Lopes-Virella Maria F
Atherogenesis and the humoral immune response to modified lipoproteins.
Atherosclerosis 2008;200(2):239-46.
-
2008: Virella Gabriel; Carter Rickey E; Saad Antonio; Crosswell Edward G; Game B Andrew; Lopes-Virella Maria F
Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy.
Clinical immunology (Orlando, Fla.) 2008;127(3):394-400.
-
2008: Jaffa Ayad A; Usinger William R; McHenry M Brent; Jaffa Miran A; Lipstiz Stuart R; Lackland Daniel; Lopes-Virella Maria; Luttrell Louis M; Wilson Peter W F;
Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes.
The Journal of clinical endocrinology and metabolism 2008;93(5):1893-900.
-
2008: Brock Jonathan W C; Jenkins Alicia J; Lyons Timothy J; Klein Richard L; Yim Eunsil; Lopes-Virella Maria; Carter Rickey E; Thorpe Suzanne R; Baynes John W
Increased methionine sulfoxide content of apoA-I in type 1 diabetes.
Journal of lipid research 2008;49(4):847-55.
-
2008: Nareika Alena; Im Yeong-Bin; Game Bryan A; Slate Elizabeth H; Sanders John J; London Steven D; Lopes-Virella Maria F; Huang Yan
High glucose enhances lipopolysaccharide-stimulated CD14 expression in U937 mononuclear cells by increasing nuclear factor kappaB and AP-1 activities.
The Journal of endocrinology 2008;196(1):45-55.
-
2007: Carter Rickey E; Lackland Daniel T; Cleary Patricia A; Yim Eunsil; Lopes-Virella Maria F; Gilbert Gregory E; Orchard Trevor J;
Intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification in the diabetes control and complications trial.
Diabetes care 2007;30(10):2646-8.
-
2007: Game Bryan A; He Lin; Jarido Veronica; Nareika Alena; Jaffa Ayad A; Lopes-Virella Maria F; Huang Yan
Pioglitazone inhibits connective tissue growth factor expression in advanced atherosclerotic plaques in low-density lipoprotein receptor-deficient mice.
Atherosclerosis 2007;192(1):85-91.
-
2007: Nareika A; Maldonado A; He L; Game B A; Slate E H; Sanders J J; London S D; Lopes-Virella M F; Huang Y
High glucose-boosted inflammatory responses to lipopolysaccharide are suppressed by statin.
Journal of periodontal research 2007;42(1):31-8.
-
2007: Lopes-Virella Maria F; McHenry Michael Brent; Lipsitz Stuart; Yim Eunsil; Wilson Peter F; Lackland Daniel T; Lyons Timothy; Jenkins Alicia J; Virella Gabriel;
Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes.
Atherosclerosis 2007;190(2):359-69.
-
2006: Lyons T J; Jenkins A J; Zheng D; Klein R L; Otvos J D; Yu Y; Lackland D T; McGee D; McHenry M B; Lopes-Virella M; Garvey W T;
Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
Diabetic medicine : a journal of the British Diabetic Association 2006;23(9):955-66.
-
2006: Saad Antonio F; Virella Gabriel; Chassereau Charlyne; Boackle Robert J; Lopes-Virella Maria F
OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages.
Journal of lipid research 2006;47(9):1975-83.
-
2006: Hammad Samar M; Taha Tarek A; Nareika Alena; Johnson Korey R; Lopes-Virella Maria F; Obeid Lina M
Oxidized LDL immune complexes induce release of sphingosine kinase in human U937 monocytic cells.
Prostaglandins & other lipid mediators 2006;79(1-2):126-40.
-
2006: Yishak Aklilu A; Costacou Tina; Virella Gabriel; Zgibor Janice; Fried Linda; Walsh Michael; Evans Rhobert W; Lopes-Virella Maria; Kagan Valerian E; Otvos James; Orchard Trevor J
Novel predictors of overt nephropathy in subjects with type 1 diabetes. A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications cohort.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(1):93-100.
-
2005: Nareika Alena; He Lin; Game Bryan A; Slate Elizabeth H; Sanders John J; London Steven D; Lopes-Virella Maria F; Huang Yan
Sodium lactate increases LPS-stimulated MMP and cytokine expression in U937 histiocytes by enhancing AP-1 and NF-kappaB transcriptional activities.
American journal of physiology. Endocrinology and metabolism 2005;289(4):E534-42.
-
2005: Costacou Tina; Lopes-Virella Maria F; Zgibor Janice C; Virella Gabriel; Otvos Jim; Walsh Michael; Orchard Trevor J
Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
Journal of diabetes and its complications 2005;19(4):183-93.
-
2005: Lopes-Virella Maria F; Thorpe Suzanne R; Derrick M Brooks; Chassereau Charlyne; Virella Gabriel
The immunogenicity of modified lipoproteins.
Annals of the New York Academy of Sciences 2005;1043():367-78.
-
2005: Kraml Pavel J; Klein Richard L; Huang Yan; Nareika Alena; Lopes-Virella Maria F
Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes.
Metabolism: clinical and experimental 2005;54(4):453-9.
-
2005: Virella Gabriel; Derrick M Brooks; Pate Virginia; Chassereau Charlyne; Thorpe Suzanne R; Lopes-Virella Maria F
Development of capture assays for different modifications of human low-density lipoprotein.
Clinical and diagnostic laboratory immunology 2005;12(1):68-75.
-
2005: Costacou T; Zgibor J C; Evans R W; Otvos J; Lopes-Virella M F; Tracy R P; Orchard T J
The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
Diabetologia 2005;48(1):41-8.
-
2004: Maldonado Alejandro; He Lin; Game Bryan A; Nareika Alena; Sanders John J; London Steve D; Lopes-Virella Maria F; Huang Yan
Pre-exposure to high glucose augments lipopolysaccharide-stimulated matrix metalloproteinase-1 expression by human U937 histiocytes.
Journal of periodontal research 2004;39(6):415-23.
-
2004: Virella Gabriel; Thorpe Suzanne R; Alderson Nathan L; Derrick M Brooks; Chassereau Charlyne; Rhett J Matthew; Lopes-Virella Maria F
Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies.
Journal of lipid research 2004;45(10):1859-67.
-
2004: Vielma Silvana A; Mironova Marina; Ku Ja-Ran; Lopes-Virella Maria F
Oxidized LDL further enhances expression of adhesion molecules in Chlamydophila pneumoniae-infected endothelial cells.
Journal of lipid research 2004;45(5):873-80.
-
2004: Lopes-Virella Maria F; Mironova Marina; Stephan Elias; Durazo-Arvizu Ramon; Virella Gabriel
Role of simvastatin as an immunomodulator in type 2 diabetes.
Diabetes care 2004;27(4):908-13.
-
2003: Lopes-Virella Maria F; Virella Gabriel
The role of immune and inflammatory processes in the development of macrovascular disease in diabetes.
Frontiers in bioscience : a journal and virtual library 2003;8():s750-68.
-
2003: Game Bryan A; Xu Minfu; Lopes-Virella Maria F; Huang Yan
Regulation of MMP-1 expression in vascular endothelial cells by insulin sensitizing thiazolidinediones.
Atherosclerosis 2003;169(2):235-43.
-
2003: Virella Gabriel; Lopes-Virella Maria F
Lipoprotein autoantibodies: measurement and significance.
Clinical and diagnostic laboratory immunology 2003;10(4):499-505.
-
2003: Fu Yuchang; Huang Yan; Bandyopadhyay Sumita; Virella Gabriel; Lopes-Virella Maria F
LDL immune complexes stimulate LDL receptor expression in U937 histiocytes via extracellular signal-regulated kinase and AP-1.
Journal of lipid research 2003;44(7):1315-21.
-
2003: Vielma Silvana A; Krings Gregor; Lopes-Virella Maria F
Chlamydophila pneumoniae induces ICAM-1 expression in human aortic endothelial cells via protein kinase C-dependent activation of nuclear factor-kappaB.
Circulation research 2003;92(10):1130-7.
-
2003: Virella Gabriel; Lopes-Virella Maria F
Humoral immunity and atherosclerosis.
Nature medicine 2003;9(3):243-4; author reply 244-5.
-
2003: Virella Gabriel; Thorpe Suzanne R; Alderson Nathan L; Stephan Elias M; Atchley Daniel; Wagner Francesco; Lopes-Virella Maria F;
Autoimmune response to advanced glycosylation end-products of human LDL.
Journal of lipid research 2003;44(3):487-93.
-
2002: Fu Yuchang; Luo Nanlan; Lopes-Virella Maria F; Garvey W Timothy
The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages.
Atherosclerosis 2002;165(2):259-69.
-
2002: Atchley D H; Lopes-Virella M F; Zheng D; Kenny D; Virella G
Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy.
Diabetologia 2002;45(11):1562-71.
-
2002: Virella G; Atchley D; Koskinen Sinikka; Zheng D; Lopes-Virella Maria F;
Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL.
Clinical immunology (Orlando, Fla.) 2002;105(1):81-92.
-
2002: Vielma Silvana; Virella Gabriel; Gorod Adam; Lopes-Virella Maria
Chlamydophila pneumoniae infection of human aortic endothelial cells induces the expression of FC gamma receptor II (FcgammaRII).
Clinical immunology (Orlando, Fla.) 2002;104(3):265-73.
-
2002: Eckel Robert H; Wassef Momtaz; Chait Alan; Sobel Burton; Barrett Eugene; King George; Lopes-Virella Maria; Reusch Jane; Ruderman Neil; Steiner George; Vlassara Helen
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes.
Circulation 2002;105(18):e138-43.
-
2002: Anderson Fran; Game Bryan A; Atchley Dan; Xu Minfu; Lopes-Virella Maria F; Huang Yan
IFN-gamma pretreatment augments immune complex-induced matrix metalloproteinase-1 expression in U937 histiocytes.
Clinical immunology (Orlando, Fla.) 2002;102(2):200-7.
-
2002: Fu Yuchang; Luo Nanlan; Lopes-Virella Maria F
Upregulation of interleukin-8 expression by prostaglandin D2 metabolite 15-deoxy-delta12, 14 prostaglandin J2 (15d-PGJ2) in human THP-1 macrophages.
Atherosclerosis 2002;160(1):11-20.
-
2001: Song L; Xu M; Lopes-Virella M F; Huang Y
Quercetin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells through extracellular signal-regulated kinase.
Archives of biochemistry and biophysics 2001;391(1):72-8.
-
2001: Huang Y; Song L; Wu S; Fan F; Lopes-Virella M F
Oxidized LDL differentially regulates MMP-1 and TIMP-1 expression in vascular endothelial cells.
Atherosclerosis 2001;156(1):119-25.
-
2001: Klein R L; Ascenção J L; Mironova M; Huang Y; Lopes-Virella M F
Effect of inflammatory cytokines on the metabolism of low-density lipoproteins by human vascular endothelial cells.
Metabolism: clinical and experimental 2001;50(1):99-106.
-
2001: Takei A; Huang Y; Lopes-Virella M F
Expression of adhesion molecules by human endothelial cells exposed to oxidized low density lipoprotein. Influences of degree of oxidation and location of oxidized LDL.
Atherosclerosis 2001;154(1):79-86.
-
2000: Huang Y; Fleming A J; Wu S; Virella G; Lopes-Virella M F
Fc-gamma receptor cross-linking by immune complexes induces matrix metalloproteinase-1 in U937 cells via mitogen-activated protein kinase.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(12):2533-8.
-
2000: Fu Y; Luo N; Lopes-Virella M F
Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages.
Journal of lipid research 2000;41(12):2017-23.
-
2000: Lopes-Virella M F; Koskinen S; Mironova M; Horne D; Klein R; Chassereau C; Enockson C; Virella G
The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA.
Atherosclerosis 2000;152(1):107-15.
-
2000: Mironova M A; Klein R L; Virella G T; Lopes-Virella M F
Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.
Diabetes 2000;49(6):1033-41.
-
2000: Thomas J C; Lopes-Virella M F; Del Bene V E; Cerveny J D; Taylor K B; McWhorter L S; Bultemeier N C
Use of fenofibrate in the management of protease inhibitor-associated lipid abnormalities.
Pharmacotherapy 2000;20(6):727-34.
-
2000: Virella G; Koskinen S; Krings G; Onorato J M; Thorpe S R; Lopes-Virella M
Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies.
Clinical immunology (Orlando, Fla.) 2000;95(2):135-44.
-
1999: Huang Y; Mironova M; Lopes-Virella M F
Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(11):2640-7.
-
1999: Huang Y; Jaffa A; Koskinen S; Takei A; Lopes-Virella M F
Oxidized LDL-containing immune complexes induce Fc gamma receptor I-mediated mitogen-activated protein kinase activation in THP-1 macrophages.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(7):1600-7.
-
1999: Orchard T J; Virella G; Forrest K Y; Evans R W; Becker D J; Lopes-Virella M F
Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study.
Diabetes 1999;48(7):1454-8.
-
1999: Lopes-Virella M F; Virella G; Orchard T J; Koskinen S; Evans R W; Becker D J; Forrest K Y
Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Clinical immunology (Orlando, Fla.) 1999;90(2):165-72.
-
1999: Islam S; Gutin B; Treiber F; Hobbs G; Kamboh I; Lopes-Virella M
Association of apolipoprotein A phenotypes and oxidized low-density lipoprotein immune complexes in children.
Archives of pediatrics & adolescent medicine 1999;153(1):57-62.
-
1998: Willi S M; O'Rear D; Garvey W T; Colwell J A; Buse M G; Jaffa A; Lopes-Virella M; Wood D; Mayfield R K; Wallace P; Hermayer K L; Jenkins A J; Lyons T; Mayer-Davis E
Diabetes research in South Carolina: past, present, and future.
Journal of the South Carolina Medical Association (1975) 1998;94(11):502-8.
-
1998: Koskinen S; Enockson C; Lopes-Virella M F; Virella G
Preparation of a human standard for determination of the levels of antibodies to oxidatively modified low-density lipoproteins.
Clinical and diagnostic laboratory immunology 1998;5(6):817-22.
-
1997: Lopes-Virella M F; Binzafar N; Rackley S; Takei A; La Via M; Virella G
The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor.
Atherosclerosis 1997;135(2):161-70.
-
1997: Mironova M; Virella G; Virella-Lowell I; Lopes-Virella M F
Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls.
Clinical immunology and immunopathology 1997;85(1):73-82.
-
1997: Huang Y; Ghosh M J; Lopes-Virella M F
Transcriptional and post-transcriptional regulation of LDL receptor gene expression in PMA-treated THP-1 cells by LDL-containing immune complexes.
Journal of lipid research 1997;38(1):110-20.
-
1996: Lopes-Virella M F; Virella G
Modified lipoproteins, cytokines and macrovascular disease in non-insulin-dependent diabetes mellitus.
Annals of medicine 1996;28(4):347-54.
-
1996: Lopes-Virella M F; Virella G
Cytokines, modified lipoproteins, and arteriosclerosis in diabetes.
Diabetes 1996;45 Suppl 3():S40-4.
-
1996: Jenkins A J; Klein R L; Chassereau C N; Hermayer K L; Lopes-Virella M F
LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation.
Diabetes 1996;45(6):762-7.
-
1996: Lopes-Virella M F; Klein R L; Virella G
Modification of lipoproteins in diabetes.
Diabetes/metabolism reviews 1996;12(1):69-90.
-
1996: Mironova M; Virella G; Lopes-Virella M F
Isolation and characterization of human antioxidized LDL autoantibodies.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(2):222-9.
-
1995: Klein R L; Laimins M; Lopes-Virella M F
Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects.
Diabetes 1995;44(9):1093-8.
-
1995: Jokl R; Klein R L; Lopes-Virella M F; Colwell J A
Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes.
Diabetes care 1995;18(8):1150-5.
-
1995: Virella G; Muñoz J F; Galbraith G M; Gissinger C; Chassereau C; Lopes-Virella M F
Activation of human monocyte-derived macrophages by immune complexes containing low-density lipoprotein.
Clinical immunology and immunopathology 1995;75(2):179-89.
-
1995: Virella G; Mironova M; Lopes-Virella M F
Comparing assays of antibodies to modified low-density lipoproteins.
Clinical chemistry 1995;41(2):324-5.
-
1994: Lopes-Virella M F; Virella G
Atherosclerosis and autoimmunity.
Clinical immunology and immunopathology 1994;73(2):155-67.
-
1994: Jokl R; Laimins M; Klein R L; Lyons T J; Lopes-Virella M F; Colwell J A
Platelet plasminogen activator inhibitor 1 in patients with type II diabetes.
Diabetes care 1994;17(8):818-23.
-
1993: Lopes-Virella M F
Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease.
European heart journal 1993;14 Suppl K():118-24.
-
1993: Klein R L; Lopes-Virella M F
Metabolism by human endothelial cells of very low density lipoprotein subfractions isolated from type 1 (insulin-dependent) diabetic patients.
Diabetologia 1993;36(3):258-64.
-
1993: Virella G; Virella I; Leman R B; Pryor M B; Lopes-Virella M F
Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers.
International journal of clinical & laboratory research 1993;23(2):95-101.
-
1992: Gisinger C; Lopes-Virella M F
Lipoprotein-immune complexes and diabetic vascular complications.
Diabetes 1992;41 Suppl 2():92-6.
-
1992: Lopes-Virella M F; Virella G
Immune mechanisms of atherosclerosis in diabetes mellitus.
Diabetes 1992;41 Suppl 2():86-91.
-
1992: Klein R L; Wohltmann H J; Lopes-Virella M F
Influence of glycemic control on interaction of very-low- and low-density lipoproteins isolated from type I diabetic patients with human monocyte-derived macrophages.
Diabetes 1992;41(10):1301-7.
-
1992: Lopes-Virella M F; Virella G
Lipoproteins and immune responses in the vascular wall and their contribution to atherosclerosis in diabetes.
Metabolism: clinical and experimental 1992;41(5 Suppl 1):11-5.
-
1991: Virella G; Fourspring K; Hyman B; Haskill-Stroud R; Long L; Virella I; La Via M; Gross A J; Lopes-Virella M
Immunosuppressive effects of fish oil in normal human volunteers: correlation with the in vitro effects of eicosapentanoic acid on human lymphocytes.
Clinical immunology and immunopathology 1991;61(2 Pt 1):161-76.
-
1991: Lopes-Virella M F; Griffith R L; Shunk K A; Virella G T
Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(5):1356-67.
-
1991: Gisinger C; Virella G T; Lopes-Virella M F
Erythrocyte-bound low-density lipoprotein immune complexes lead to cholesteryl ester accumulation in human monocyte-derived macrophages.
Clinical immunology and immunopathology 1991;59(1):37-52.
-
1991: Lopes-Virella M F; Virella G
Immune mechanisms in the pathogenesis of atherosclerosis.
Advances in experimental medicine and biology 1991;285():383-92.
-
1990: Klein R L; Lyons T J; Lopes-Virella M F
Metabolism of very low- and low-density lipoproteins isolated from normolipidaemic type 2 (non-insulin-dependent) diabetic patients by human monocyte-derived macrophages.
Diabetologia 1990;33(5):299-305.
-
1989: Klein R L; Lyons T J; Lopes-Virella M F
Interaction of very-low-density lipoprotein isolated from type I (insulin-dependent) diabetic subjects with human monocyte-derived macrophages.
Metabolism: clinical and experimental 1989;38(11):1108-14.
-
1989: Vaughn M; Virella G; Lopes-Virella M F
Diabetes, autoimmunity, and arteriosclerosis.
Clinical immunology and immunopathology 1989;52(3):414-20.
-
1989: Marken P A; Weart C W; Carson D S; Gums J G; Lopes-Virella M F
Effects of magnesium oxide on the lipid profile of healthy volunteers.
Atherosclerosis 1989;77(1):37-42.
-
1988: Watanabe J; Wohltmann H J; Klein R L; Colwell J A; Lopes-Virella M F
Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients.
Diabetes 1988;37(12):1652-7.
-
1988: Colwell J A; Lopes-Virella M F
A review of the development of large-vessel disease in diabetes mellitus.
The American journal of medicine 1988;85(5A):113-8.
-
1988: Griffith R L; Virella G T; Stevenson H C; Lopes-Virella M F
Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation.
The Journal of experimental medicine 1988;168(3):1041-59.
-
1988: Lopes-Virella M F; Klein R L; Lyons T J; Stevenson H C; Witztum J L
Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages.
Diabetes 1988;37(5):550-7.
-
1987: Lyons T J; Klein R L; Baynes J W; Stevenson H C; Lopes-Virella M F
Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins.
Diabetologia 1987;30(12):916-23.
-
1987: Virella G; Lopes-Virella M F
Infections and atherosclerosis.
Transplantation proceedings 1987;19(4 Suppl 5):26-35.
-
1987: Lopes-Virella M F; Colwell J A
Pharmacological treatment of lipid disorders in diabetes mellitus.
Diabetes/metabolism reviews 1987;3(3):691-722.
-
1987: Lopes-Virella M F; Klein R L; Stevenson H C
Low density lipoprotein metabolism in human macrophages stimulated with microbial or microbial-related products.
Arteriosclerosis (Dallas, Tex.) 1987;7(2):176-84.
-
1987: Lopes-Virella M F
[Metabolism of lipoproteins in diabetes mellitus]
Journées annuelles de diabétologie de l'Hôtel-Dieu 1987;():55-66.
-
1986: Lyons T J; Baynes J W; Patrick J S; Colwell J A; Lopes-Virella M F
Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control.
Diabetologia 1986;29(10):685-9.
-
1985: Lopes-Virella M F; Virella G
Immunological and microbiological factors in the pathogenesis of atherosclerosis.
Clinical immunology and immunopathology 1985;37(3):377-86.
-
1985: Lopes-Virella M F; Sherer G; Wohltmann H; Sens D; Colwell J A
Diabetic lipoprotein deficient serum: its effect in low density lipoprotein (LDL) uptake and degradation by fibroblasts.
Metabolism: clinical and experimental 1985;34(12):1079-85.
-
1985: Mayfield R K; Halushka P V; Wohltmann H J; Lopes-Virella M; Chambers J K; Loadholt C B; Colwell J A
Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients.
Diabetes 1985;34(11):1127-33.
-
1985: Winocour P D; Lopes-Virella M; Laimins M; Colwell J A
Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
The Journal of laboratory and clinical medicine 1985;106(3):319-25.
-
1985: Lopes-Virella M
Abnormal metabolism of low density lipoprotein in diabetes mellitus.
Hormone and metabolic research. Supplement series 1985;15():83-7.
-
1983: Colwell J A; Winocour P D; Lopes-Virella M; Halushka P V
New concepts about the pathogenesis of atherosclerosis in diabetes mellitus.
The American journal of medicine 1983;75(5B):67-80.
-
1983: Winocour P D; Lopes-Virella M; Laimins M; Colwell J A
Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
The Journal of laboratory and clinical medicine 1983;102(5):795-804.
-
1983: Virella G; Lopes-Virella M F; Shuler C; Sherwood T; Espinoza G A; Winocour P; Colwell J A
Release of PAF by human polymorphonuclear leucocytes stimulated by immune complexes bound to Sepharose particles and human erythrocytes.
Immunology 1983;50(1):43-51.
-
1983: Lopes-Virella M F; Wohltmann H J; Mayfield R K; Loadholt C B; Colwell J A
Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients. A longitudinal study.
Diabetes 1983;32(1):20-5.
-
1982: Lopes-Virella M F; Sherer G K; Lees A M; Wohltmann H; Mayfield R; Sagel J; LeRoy E C; Colwell J A
Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control.
Diabetologia 1982;22(6):430-6.
-
1981: Lopes-Virella M F; Wohltmann H J; Loadholt C B; Buse M G
Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control.
Diabetologia 1981;21(3):216-23.
-
1981: Virella G; Wohltmann H; Sagel J; Lopes-Virella M F; Kilpatrick M; Phillips C; Colwell J
Soluble immune complexes in patients with diabetes mellitus: detection and pathological significance.
Diabetologia 1981;21(3):184-91.
-
1981: Colwell J A; Lopes-Virella M; Halushka P V
Pathogenesis of atherosclerosis in diabetes mellitus.
Diabetes care 1981;4(1):121-33.
-
1980: Lopes-Virella M F; Virella G; Evans G; Malenkos S B; Colwell J A
Immunonephelometric assay of human apolipoprotein AI.
Clinical chemistry 1980;26(8):1205-8.
-
1980: Gordon L; Mayfield R K; Levine J H; Lopes-Virella M F; Sagel J; Buse M G
Failure to visualize adrenal glands in a patient with bilateral adrenal hyperplasia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1980;21(1):49-51.
-
1979: Sagel J; Lopes-Virella M F; Levine J H; Colwell J A
Decreased high density lipoprotein cholesterol in hypopituitarism.
The Journal of clinical endocrinology and metabolism 1979;49(5):753-6.
-
1979: Lopes-Virella M; Virella G; Debeukelaer M; Owens C J; Colwell J A
Urinary high density lipoprotein in minimal change glomerular disease and chronic glomerulopathies.
Clinica chimica acta; international journal of clinical chemistry 1979;94(1):73-81.
-
1979: Lopes-Virella M F; Virella G; Rosebrock G; Sagel J; Gonzalez J; Colwell J
Early diagnosis of renal malfunction in diabetics. Abnormal proteinuria revealed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Diabetologia 1979;16(3):165-71.
-
1979: Virella G; Munoz J; Lopes-Virella M F; Ward B; Gadsden R
Rapid immunochemical determination of free hemoglobin in plasma and urine with a laser nephelometer.
Clinical chemistry 1979;25(3):497-9.
-
1979: Colwell J A; Halushka P V; Sarji K E; Lopes-Virella M F; Sagel J
Vascular disease in diabetes: pathophysiological mechanisms and therapy.
Archives of internal medicine 1979;139(2):225-30.
-
1978: Virella G; Lopes-Virella M F; Levine J; Ogawa M; Gonzalez J
"Idiopathic" Bence-Jones proteinuria.
Acta haematologica 1978;60(5):269-79.
-
1977: Virella G; Lopes-Virella M F
New approaches to the study of proteinuria.
Clinical chemistry 1977;23(9):1793-4.
-
1977: Lopes-Virella M F; Stone P G; Colwell J A
Serum high density lipoprotein in diabetic patients.
Diabetologia 1977;13(4):285-91.
-
1977: Virella G; Monteiro J M; Lopes-Virella M F; Ducla Soares A; Fudenberg H H
Asynchronous development of two monoclonal proteins (IgM lambda and delta 1 chains) in a patient with abdominal lymphoma.
Cancer 1977;39(5):2247-53.
-
1977: Lopes-Virella M F; Stone P; Ellis S; Colwell J A
Cholesterol determination in high-density lipoproteins separated by three different methods.
Clinical chemistry 1977;23(5):882-4.
-
1976: Lopes-Virella M F; Sarji K; Virella G; Colwell J A
Platelet lipoproteins. A comparative study with serum lipoproteins.
Biochimica et biophysica acta 1976;439(2):339-48.
-
1976: Lopes-Virella M F; Colwell J A
Serum-high-density-lipoprotein in diabetic patients.
Lancet 1976;1(7972):1291-2.
-
1970: Virella G; Lopes-Virella M F
Effects of therapeutically useful thiols (DL-penicillamine and alpha-mercaptopropionylglycine) on immunoglobulins.
Clinical and experimental immunology 1970;7(1):85-107.
Sign-in to see more
